BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19663687)

  • 1. Economic burden of psoriasis compared to the general population and stratified by disease severity.
    Yu AP; Tang J; Xie J; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Curr Med Res Opin; 2009 Oct; 25(10):2429-38. PubMed ID: 19663687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
    Opmeer BC; Heydendael VM; De Borgie CA; Spuls PI; Bossuyt PM; Bos JD; De Rie MA
    Arch Dermatol; 2004 Jun; 140(6):685-90. PubMed ID: 15210458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of psoriasis on health care costs and patient work loss.
    Fowler JF; Duh MS; Rovba L; Buteau S; Pinheiro L; Lobo F; Sung J; Doyle JJ; Swensen A; Mallett DA; Kosicki G
    J Am Acad Dermatol; 2008 Nov; 59(5):772-80. PubMed ID: 19119095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.
    Nguyen HQ; Ackermann RT; Berke EM; Cheadle A; Williams B; Lin E; Maciejewski ML; LoGerfo JP
    Diabetes Care; 2007 Jan; 30(1):43-8. PubMed ID: 17192331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of economic costs associated with transfusion dependence in adults with MDS.
    Frytak JR; Henk HJ; De Castro CM; Halpern R; Nelson M
    Curr Med Res Opin; 2009 Aug; 25(8):1941-51. PubMed ID: 19552620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
    Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
    Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
    Kulkarni AS; Balkrishnan R; Richmond D; Pearce DJ; Feldman SR
    J Am Acad Dermatol; 2005 Jan; 52(1):27-31. PubMed ID: 15627077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
    Berger K; Ehlken B; Kugland B; Augustin M
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):511-8. PubMed ID: 15967010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden - a cross-sectional study.
    Ghatnekar O; Ljungberg A; Wirestrand LE; Svensson A
    Eur J Dermatol; 2012; 22(2):238-45. PubMed ID: 22361745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based nested case-control study of the costs of hip and knee replacement surgery.
    Hawker GA; Badley EM; Croxford R; Coyte PC; Glazier RH; Guan J; Harvey BJ; Williams JI; Wright JG
    Med Care; 2009 Jul; 47(7):732-41. PubMed ID: 19536034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.
    Han C; Lofland JH; Zhao N; Schenkel B
    J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ; Feldman SR; Camacho FT; Timothy Whitmire J; Nahata MC; Balkrishnan R
    J Dermatolog Treat; 2006; 17(5):294-301. PubMed ID: 17092860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II).
    Carrascosa JM; Pujol R; Daudén E; Hernanz-Hermosa JM; Bordas X; Smandia JA; Ferrándiz C
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):840-5. PubMed ID: 16898908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization associated with dyspepsia in patients with arthritis.
    Zhao SZ; Arguelles LM; Dedhiya SD; Morgan DG
    Am J Manag Care; 1999 Oct; 5(10):1285-95. PubMed ID: 10622994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.